Guines LLC bought $2.8M of biote (BTMD)
Executed Mar 13 2025, disclosed Mar 17 2025, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Mar 17 2025), the stock returned -4.1% (delay-adjusted); from the execution session (Mar 13 2025), -9.5%. Derived: entry at the session's open, exit at the close 20 sessions later.
Guines LLC (10% owner) filed 2 Form 4 reports as a reporting entity in the past 24 months (2 purchases, 0 sales), most often in biote Corp. (BTMD). Across 2 priced purchase filings, the average 21-session return was -5.5% from execution and +6.1% from disclosure (delay-adjusted; derived). The largest single filing was $2.8M of BTMD (856,509 sh across 2 lots, as filed), executed Mar 13 2025.
Healthcare · biote Corp. operates in practice-building business within the hormone optimization space
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→34,907 sh × $3.21
Exec Apr 8 2025
Filed Apr 10 2025 · 5:30 PM ET